Does targeting of CDC20 via small interfering RNA cause enhancement of the cytotoxicity of chemoradiation?
CDC20 is a promising target for gene specific therapy in human pancreatic cancer.
Our study demonstrated that ASCT in HIV-infected persons with lymphoma does not worsen the initial immune impairment and does not enhance viral replication or the peripheral HIV reservoir in the long term.